Beauveria bassiana vs Metarhizium anisopliae: Which Biocontrol Fungus Fits Your Pest Program?

If you’re choosing between Beauveria bassiana and Metarhizium anisopliae (often marketed today as Metarhizium brunneum for some commercial strains), don’t frame it as “which one is stronger.” Frame it as which one fits your pest ecology and application environment.

• Beauveria bassiana is typically positioned as a broad-spectrum foliar contact mycoinsecticide for soft-bodied and canopy pests—performance hinges on coverage + humidity/leaf-wetness windows and on the specific strain you’re buying.
• Metarhizium (anisopliae / brunneum) is often selected when you need a stronger “soil + foliar” biocontrol story (depending on strain/label), and some well-known commercial strains (e.g., F52 / Met52) are explicitly described as infecting insects such as beetle larvae and ticks and are regulated with site constraints (e.g., limited outdoor uses not near water).

Choose by target pest + habitat (leaf surface vs soil/thatched zone) + operational conditions + local registration/label scope. Always follow the approved label and local regulations.

What Beauveria bassiana and Metarhizium anisopliae are

Both are entomopathogenic fungi (EPFs) used as microbial insecticides. They control pests via contact infection, not by requiring the insect to ingest a toxin. That distinction is exactly why these products are often used in resistance management programs and IPM—when you need a different pressure mechanism than conventional chemistry.

A critical commercial nuance: strain identity matters.

• For Beauveria, strain names like GHA are commonly referenced in regulatory and market materials.
• For Metarhizium, you will see F52 / Met52, and many market materials now state this strain is Metarhizium brunneum (formerly labeled as M. anisopliae in older documents).

How they work in plain language

EPFs follow a predictable infection sequence:

• Spore contact and adhesion on the insect cuticle
• Germination under suitable moisture/temperature
• Penetration through the cuticle (enzymes + mechanical pressure)
• Internal growth in the insect body, leading to death
• Sporulation on the cadaver (under favorable humidity), which supports secondary spread

The practical translation is simple: results depend on getting viable spores onto the pest, and keeping conditions suitable long enough for infection to establish. This is why “spray quality” (coverage) and “microclimate” (humidity, leaf wetness, temperature) are the true performance levers—not marketing claims.

Key differences that matter in procurement and field performance

1) Best-fit pest ecology: canopy pests vs soil-linked pests

Beauveria bassiana is frequently used where pest pressure is driven by insects that live and feed on the plant surface (e.g., greenhouse canopy pests). Regulatory and extension summaries describe broad insect targets and wide site use (strain-dependent).

Metarhizium often shows up when programs include soil-associated or habitat-structured pests (and, for specific strains such as F52/Met52, public documents explicitly discuss ticks and beetle larvae).

How to use this commercially:

• If the buyer’s pain point is persistent canopy pressure and they can manage humidity/coverage, Beauveria is typically easier to position.
• If the buyer’s pain point includes soil/thatched zone exposure (or “yard/ground interface” pests in non-food settings), Metarhizium strains are often easier to justify—again, label/strain dependent.

2) Regulatory/label scope can be very different (don’t assume equivalence)

A major “gotcha” in trade: Beauveria and Metarhizium products do not share identical registration footprints.

• EPA’s biopesticide fact sheet for Beauveria bassiana strain GHA states it can be used on all food crops and many non-food sites (label-controlled).
• EPA’s summary for Metarhizium anisopliae strain F52 describes approval as a microbial pesticide for non-food use in greenhouses and nurseries, and limited outdoor sites not near bodies of water.

Even if your market is outside the U.S., these documents illustrate the core rule: registration is strain- and use-pattern specific. A buyer expects you to confirm status for the target market, not generalize from “it’s a biopesticide.”

3) Non-target narrative: “soft” does not mean “zero-impact”

Buyers often choose EPFs to reduce broad-spectrum chemical pressure, but a credible page must still acknowledge non-target considerations.

• Regulatory materials for Beauveria strains emphasize low human health concern when used as labeled.
• At the same time, recent consensus/regulatory-style reviews discuss that biopesticide applications can affect pollination services depending on exposure and context—so the right stance is “minimize direct pollinator exposure”, not “pollinator-safe by default.”

This is where you build trust: you position EPFs as selective tools, and you communicate exposure discipline as part of professional stewardship.

4) Commercial naming: Metarhizium anisopliae vs Metarhizium brunneum

If your customer audits labels and technical files, this matters. Some widely used commercial products now explicitly market Metarhizium brunneum strain F52 (formerly Metarhizium anisopliae).

For content and sales enablement:

• Use both names once early: “Metarhizium anisopliae (often M. brunneum for strain F52/Met52 products)”
• Then stick to the name on your label and dossier.

When each one is a stronger fit

Use this as a buyer-facing decision logic (no “how-to,” just fit).

Choose Beauveria bassiana when

• The program is foliar/canopy-driven, especially in controlled environments (greenhouses, protected crops).
• The buyer can execute coverage discipline and understands that performance is biological (not “instant knockdown”).
• The target market expects food-crop applicability under a recognized strain/label footprint (strain-dependent).

Choose Metarhizium (anisopliae / brunneum) when

• The pest ecology includes soil/ground interface dynamics, or the program is designed for both soil and foliar pest management depending on label and formulation.
• The buyer’s compliance team needs a clear, documented use pattern boundary (some strains have explicit site restrictions).
• The commercial dossier emphasizes a specific strain with established positioning (e.g., F52/Met52 lineage).

What drives results (and what causes failures)

A realistic page must explain why results vary—this is where you outperform generic competitor copy.

• Viability is everything: EPFs are living propagules. Product age, storage, transport temperature, and formulation stability can change outcomes.
• Microclimate controls infection: humidity/leaf wetness and temperature govern germination and penetration.
• Contact is the gate: if spores don’t reach the pest, there’s no control.
• Program conflicts exist: broad fungicide pressure can reduce fungal biocontrol performance in some programs—so compatibility planning is part of professional execution (always follow the label).

Quick comparison table

Dimension	Beauveria bassiana (example: strain GHA)	Metarhizium anisopliae / Metarhizium brunneum (example: strain F52/Met52)
Category	Entomopathogenic fungus (microbial insecticide)	Entomopathogenic fungus (microbial insecticide)
How it kills	Contact infection via cuticle penetration and internal colonization	Same core infection model
Typical positioning	Broad-spectrum foliar biocontrol; strain-dependent targets and sites	Often positioned for soil + foliar programs (strain/label dependent); public docs highlight ticks and beetle larvae for F52
Label scope signal (illustrative, not universal)	EPA fact sheet for strain GHA describes use on all food crops and many non-food sites	EPA summary for strain F52 describes non-food greenhouse/nursery use and limited outdoor sites not near water
Naming risk	Strain identity is crucial (GHA vs other strains)	Taxonomy/name on label matters (F52 products often marketed as M. brunneum)
Non-target narrative	Label-first stewardship; avoid “zero impact” claims; manage pollinator exposure	Label-first stewardship; site restrictions can be tighter for some strains

Sources used for the table’s regulatory positioning: EPA fact sheet for B. bassiana GHA and EPA summary for M. anisopliae F52; commercial documentation noting Met52 → M. brunneum naming.

FAQs

Are Beauveria bassiana and Metarhizium anisopliae “organic”?

Some products may be accepted in certain organic programs depending on certification frameworks and formulations. The correct, auditable answer is: check the product’s registration/label and the destination program requirements (and, where relevant, the listing status used by that market).

Do these fungi work as fast as chemical insecticides?

Typically, no. EPFs are biological agents; they require contact, infection establishment, and internal growth. Speed varies by pest, conditions, and formulation. Set expectations around program stability rather than “same-day knockdown.”

Can I position either one as “safe for beneficial insects”?

Don’t use blanket claims. A more credible statement is: EPFs can be more selective than many broad-spectrum insecticides, but non-target exposure still matters—especially for pollinators if they are directly contacted.

Why does the same species name perform differently across suppliers?

Because performance can change with strain identity, viable spore concentration, formulation quality, and storage/transport stability. If your COA doesn’t reflect viable counts and QA controls, buyers will assume “unknown quality.”

Is Metarhizium anisopliae the same as Metarhizium brunneum?

Not always. Some commercial products (notably F52/Met52 lineage) are marketed as M. brunneum strain F52, and older references may still use M. anisopliae. Use the name that matches your label and dossier.

Next step: make your choice “label-ready”

If you share your target pest list, crop system (open field vs greenhouse), and target market registration requirements, you can rapidly narrow the decision to:

• the right species + strain,
• the right formulation format for your use environment,
• and the right documentation package (COA/SDS/TDS + traceability) that a distributor or registrant can defend.